INTRODUCTION
Hepatolithiasis is defined as the presence of stones within the intrahepatic bile ducts, proximal to the right and left hepatic ducts. Hepatolithiasis has a poor prognosis due to other associated complications such as recurrent cholangitis, biliary strictures, liver abscess, liver atrophy, or cirrhosis. 1, 2 Additionally, hepatolithiasis is an important leading cause of intrahepatic cholangiocarcinoma. 3, 4 Hepatolithiasis treatment includes both non-surgical and surgical approaches. Non-surgical procedures, such as percutaneous transhepatic cholangioscopic lithotripsy, show a high clearance rate of intrahepatic stones; however, these treatments are not effective for preventing recurrence of hepatolithiasis and removal of benign biliary strictures. [5] [6] [7] Surgical treatment can be divided into minor and major hepatectomies, depending on the resection range. The range of minor hepatectomy is generally limited to atrophic segments and intrahepatic stones. In this context, a residual intrahepatic biliary stricture may remain, which is a risk factor for hepatolithiasis. Unlike minor hepatectomy, the range of major hepatectomy includes all intrahepatic duct stones and a wider segment, including the intrahepatic biliary strictures. Thus, major hepatectomy can be the fundamental treatment for hepatolithiasis by eliminating not only the stones but also the benign biliary stricture, which is a crucial cause of the stones.
Previous studies have reported the rate of unidentified underlying cholangiocarcinoma before hepatectomy in pa- tients with hepatolithiasis. 2, 8 In these reports, it is uncertain whether the resection range includes all intrahepatic biliary strictures and their segments. To confirm the incidence of underlying biliary neoplasm in patients with hepatolithiasis, we need to investigate patients who underwent major hepatectomy for both hepatolithiasis and intrahepatic biliary strictures.
Here, we evaluated the incidence of underlying biliary neoplasm in patients who underwent major hepatectomy for benign hepatolithiasis, based on preoperative diagnosis.
MATERIALS AND METHODS

Patients and outcome evaluation
The medical records of Chonnam National University One patient each in the benign stricture group and in the biliary neoplasm group had a biliary stricture at the confluence of the right and left hepatic ducts. A stricture at the third branch of bile duct was seen in 1 patient in the biliary stricture group. Postoperative pathological examination confirmed that the location of the intrahepatic strictures was consistent with that of concomitant biliary neoplasms ( Table 2 ).
The variables considered were sex, age, the type of surgical procedure, location of the biliary stricture, preoperative symptoms, preoperative serum CA 19-9, presence of atrophy in preoperative image, and preoperative serum total bilirubin level. The main symptoms of patients with hepatolithiasis were abdominal pain, fever, jaundice, and weight loss. Results from the statistical analysis showed no significant difference when comparing the benign stricture group and the pathologically proven biliary neoplasm group. Although sex appeared to be significant, it was not a definitive factor (Table 3) . (Table 4) .
DISCUSSION
Epidemiological, pathological, and genetic studies demonstrate a relationship between hepatolithiasis and cholangiocarcinoma. [12] [13] [14] The overall incidence of hepatolithiasis-related cholangiocarcinoma has been reported as 5% to 13%. [15] [16] [17] In a cohort study, 65 years or older (hazard ratio, 3.029; p-value, 0.017) and having stone removal only as the initial treatment (hazard ratio, 2.873; p-value, 0.012) were found to be significant risk factors for the development of cholangiocarcinoma. 18 The authors reported that hepatectomy could significantly reduce the risk of developing cholangiocarcinoma (hazard ratio, 0.066; p-value, 0.010). In another cohort study, it was reported that hepatectomy significantly reduced the risk of developing cholangiocarcinoma. 19 In general, hepatic resection might offer an advantage in eliminating the risk of developing cholangiocarcinoma because of complete removal of both the intrahepatic stones and the bile ducts involved, which are likely to have a hidden malignancy.
In this regard, hepatic resection could be considered as a primary treatment in hepatolithiasis.
Despite preoperative evaluations, it is still difficult to detect underlying biliary neoplasms or chlangiocarcinoma in hepatolithiasis. Catena et al. 20 reported that the rate of unrecognized cholangiocarcinoma was quite high at 11.7%, and that it might be underestimated. Although serum CA 19-9 is known as a tumor biomarker for cholangiocarcinoma, its levels could be normal or increased in benign diseases, such as in bacterial cholangitis or choledocholithiasis. 21, 22 In preoperative images or even during the surgery, a diagnosis of cholangiocarcinoma associated with hepatolithiasis is difficult, because the affected liver segment is often fibrotic and scarred. 2 Chen et al. 2 reported 2 patients (2.0%) having the tumor diagnosed during the operation, and 4 patients (3.9%) having cholangiocarcinoma diagnosed only after pathological examination. They also reported that in 1 patient (1.0%), a cholangiocarcinoma was diagnosed 7 months after the hepatic resection for hepatolithiasis, and the tumor was likely present during the surgery, but was unidentified, and the undetected cholangiocarcinoma was present in the remnant liver even after hepatectomy.
Hepatic resection is regarded as an established treatment, recommended for its ability to resolve not only the stones but also the strictures. 23, 24 Biliary strictures, found in 42% to 96% of patients with hepatolithiasis, [25] [26] [27] may be related to biliary carcinogenesis as an aspect of recurrent cholangitis, bile stasis, and bacterial infections.
Biliary stricture is associated with recurrent and chronic inflammations causing prolonged inflammation of the bile duct epithelium, leading to the subsequent development of cholangiocarcinoma. 28, 29 Up to 50% of patients with malignant biliary strictures may have coexistent hepatolithiasis. 30 To prevent the development of cholangiocarcino- There also exist concerns regarding surgical complications after major hepatectomy. The surgical techniques of hepatectomy and the perioperative management of patients have sufficiently developed in the past decade, resulting in a marked decrease in the morbidity and mortality following liver surgery. [34] [35] [36] In one study, the cumulative survival rates, excluding unrelated deaths, did not differ significantly between the hepatic resection group and the cholangioscopic lithotomy group. 25 In another study evaluating the outcome of hepatectomy for hep-atolithiasis, 7 patients (6.8%) underwent re-operation and 2 patients (1.9%) died during hospital stay. 2 In our study, 3 patients (4.1%) underwent re-operation and only 1 patient (1.4%) died during hospital stay. The rate of postoperative complication in our study was not significantly different compared to that of other studies.
Our study presents some limitations, including its retrospective nature and the relatively small number of patients involved. Also, there was no comparison of the postoperative complications in major hepatectomy and minor hepatectomy in patients with hepatolithiasis. Finally, no long-term follow-up was performed to confirm that there would be a significant difference in the development of cholangiocarcinoma between major hepatectomy and minor hepatectomy in benign hepatolithiasis.
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